• Tile
    $BCLI offers an alternative to $CUR who is becoming too expensive. Their upcoming p2 trial in the US will steel the spotlight.
    4/1/14
    Reply (17)
    • Loose Goose: I second that. at 4.4 a share CUR is running ahead of itself; just closed my position.
      4/2/14
    • JKenser: Any actual dd to your ahead of itself reasoning? Or just an opinion?
      4/2/14
    • JKenser: With an NSI566 approval for ALS CUR is a 10 billion dollar company. Just do the math. Market is overlooking the size of ALS.
      4/2/14
    • Jeffadler: $CUR is well ahead of $BCLI in trial development and agree w/JKenser re: market size. Own both and continuing to accumulate both. Very Long.
      4/3/14
    • Tile: No one is ahead.They are both running p2 trials.Each has a Ted.Just because BCLI is running it in Israel it doesn't mean that doesn't count.
      4/3/14
    • JKenser: Actually it does, have they started their US trial? It took CUR 3 years to get through safety from FDA. BCLI will have to do the same.
      4/3/14
    • JKenser: Which will mean a lot more dilution, and time. Which is why they are so cheap..
      4/3/14
    • Tile: Ok.
      4/3/14
    • JKenser: Really that's it? Just ok? I would love to debate this with you but you're not adding much valuable insight.
      4/3/14
    • fretch: not even mentioning difference in management...
      4/3/14
    • MichaelJ8: JKenser, I think Tile is saying ok because he understands you. Anyway, I am an in agreement with you as well. But, AF will post an article
      4/3/14
    • MichaelJ8: and then its all down hill.
      4/3/14
    • JKenser: He can write all the articles he wants, the data and patients will speak for themselves. I would be much obliged if he gave me a buying opp.
      4/4/14
    • Tile: Kenser they have not started in the US, but they will this summer.It won't take any 3 y from FDA to grant safety clearance. They have that
      4/4/14
    • Tile: Already from Israel. And the FDA won't put them through that again.
      4/4/14
    • JKenser: Ok, good luck with that dream.
      4/4/14
    • Tile: I am holding 100k shares for long and I bet on this for my retirement. They aren't competing. They just offer an alternative to CUR.
      4/4/14
      From other sites